Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding
Status:
Withdrawn
Trial end date:
2020-01-17
Target enrollment:
Participant gender:
Summary
This study compares two treatments for the management of heavy menstrual bleeding, ulipristal
acetate (UPA) and tranexamic acid (TEA), on health-related quality of life. Half of the
participants will receive UPA and a placebo, and the other half will receive TEA and a
placebo.